National Health Investors (NYSE: NHI) awards COO 2,370 restricted shares

Rhea-AI Filing Summary

Maingot Christian Ken reported acquisition or exercise transactions in this Form 4 filing.

NATIONAL HEALTH INVESTORS INC reported that Chief Operating Officer Christian Ken Maingot received a grant of 2,370 shares of restricted common stock on July 27, 2026. The award vests in three equal annual installments beginning July 27, 2027, subject to his continued service, and brings his direct holdings to 2,370 shares.

Insider Trade Summary

Net Buyer: 2,370 shares

Net Buy 1 txn

Insider Maingot Christian Ken

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	2,370	$0.00	$0.00

Holdings After Transaction: Common Stock — 2,370 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning July 27, 2027, subject to the reporting person's continued service through each vesting date.

Key Figures

Restricted stock grant: 2,370 shares Transaction price per share: 0.0000 per share Total direct holdings after grant: 2,370 shares +2 more

5 metrics

Restricted stock grant 2,370 shares Shares of common stock granted to COO on July 27, 2026

Transaction price per share 0.0000 per share Stated price for the restricted stock grant

Total direct holdings after grant 2,370 shares Common stock directly owned by the reporting person following the transaction

Vesting installments 3 equal annual installments Restricted stock vests over three years starting July 27, 2027

Vesting start date July 27, 2027 First vesting date for the restricted stock award

Key Terms

restricted stock, vesting date, continued service

3 terms

restricted stock financial

"Represents a grant of restricted stock that vests in three equal annual installments"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

vesting date financial

"on each anniversary of the grant date beginning July 27, 2027, subject to the reporting person's continued service through each vesting date"

continued service financial

"subject to the reporting person's continued service through each vesting date"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/30/2026 - 03:10 PM Accepted by SEC EDGAR 07/30/2026 - 03:08 PM Learn about SEC filing dates

FAQ

What insider transaction did NATIONAL HEALTH INVESTORS (NHI) report for Christian Ken Maingot?

NATIONAL HEALTH INVESTORS reported that COO Christian Ken Maingot received a grant of 2,370 shares of restricted common stock on July 27, 2026, as equity compensation, with the shares awarded at a price of 0.0000 per share.

How many NHI shares does COO Christian Ken Maingot hold after this Form 4 transaction?

Following the reported grant, COO Christian Ken Maingot directly holds 2,370 shares of NATIONAL HEALTH INVESTORS common stock. All of these shares relate to this restricted stock award disclosed in the filing.

What is the vesting schedule for the 2,370 restricted NHI shares granted to the COO?

The 2,370 restricted shares vest in three equal annual installments on each anniversary of the grant date, beginning July 27, 2027, and are subject to the reporting person’s continued service through each vesting date.

Was the NHI Form 4 grant to COO Christian Ken Maingot made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan. The reported transaction is characterized as a grant or award acquisition of restricted stock, rather than a trade under a pre-arranged 10b5-1 plan.

Did COO Christian Ken Maingot buy or sell NHI shares for cash in this Form 4?

No cash purchase or sale is reported. The Form 4 shows a grant of 2,370 restricted shares at a stated price of 0.0000 per share, reflecting an equity compensation award rather than an open-market buy or sell transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maingot Christian Ken

(Last) (First) (Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO TENNESSEE 37129

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/27/2026		A		2,370(1)	A	$0	2,370	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning July 27, 2027, subject to the reporting person's continued service through each vesting date.

	/s/ Kimberly V. Ouimet, by limited power of attorney	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)